Novo Nordisk Fined and Criticized over Falck Deal - The Copenhagen Post
8 Articles
8 Articles
The pharmaceutical giant Novo Nordisk has violated ethical rules in collaboration on weight loss programs, the board finds.
The pharmaceutical giant disagrees with the decision, but is still terminating the collaboration.
Novo Nordisk fined and criticized over Falck deal - The Copenhagen Post
The Danish pharmaceutical giant Novo Nordisk has received criticism and a fine of 45,000 kroner from the Ethical Board for the Pharmaceutical Industry (Enli) for a collaboration with Falck. DR reports this based on a decision from the independent body. Novo and Falck announced a collaboration at the beginning of the year on a weight […]
The pharmaceutical giant Novo has violated ethical rules in its collaboration on weight loss programs, the board finds.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium













